{"keywords": [{"value": "Anheuser-Busch InBev NV", "rank": "1", "name": "organizations"}, {"value": "Theranos Inc", "rank": "11", "name": "organizations"}, {"value": "Walgreen Co.", "rank": "12", "name": "organizations"}, {"value": "Cablevision Systems Corporation", "rank": "2", "name": "organizations"}, {"value": "Credit Suisse Group AG", "rank": "3", "name": "organizations"}, {"value": "Goldman Sachs Group Inc", "rank": "4", "name": "organizations"}, {"value": "KKR & Co LP", "rank": "5", "name": "organizations"}, {"value": "Molson Coors Brewing Company", "rank": "6", "name": "organizations"}, {"value": "Rite Aid Corporation", "rank": "7", "name": "organizations"}, {"value": "Securities and Exchange Commission", "rank": "8", "name": "organizations"}, {"value": "St. Joe Company", "rank": "9", "name": "organizations"}, {"value": "Starwood Hotels &amp; Resorts Worldwide Inc", "rank": "10", "name": "organizations"}, {"value": "Art", "rank": "1", "name": "subject"}, {"value": "Soros, George", "rank": "11", "name": "subject"}, {"value": "Valeant Pharmaceuticals International Inc", "rank": "12", "name": "subject"}, {"value": "Whistle-Blowers", "rank": "13", "name": "subject"}, {"value": "Barclays PLC", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "rank": "3", "name": "subject"}, {"value": "Federal Reserve System", "rank": "4", "name": "subject"}, {"value": "Hedge Funds", "rank": "5", "name": "subject"}, {"value": "Initial Public Offerings", "rank": "6", "name": "subject"}, {"value": "Interest Rates", "rank": "7", "name": "subject"}, {"value": "International Business Machines Corporation", "rank": "8", "name": "subject"}, {"value": "Libor (London Interbank Offered Rate)", "rank": "9", "name": "subject"}, {"value": "Mergers, Acquisitions and Divestitures", "rank": "10", "name": "subject"}], "headline": {"kicker": "News", "main": "Morning Agenda: Anheuser-Busch InBev and SABMiller Get More Time"}, "byline": {"original": "By AMIE TSANG", "person": [{"rank": 1, "role": "reported", "organization": "", "lastname": "TSANG", "firstname": "Amie"}]}, "web_url": "http://news.blogs.nytimes.com/2015/10/28/morning-agenda-anheuser-busch-inbev-and-sabmiller-get-more-time/", "source": "The New York Times", "subsection_name": null, "slideshow_credits": null, "type_of_material": "Blog", "_id": "56309ec538f0d8595b45ccbf", "multimedia": [], "pub_date": "2015-10-28T06:07:37Z", "print_page": null, "section_name": "Blogs", "word_count": "2172", "blog": [], "news_desk": null, "snippet": "Walgreens to Buy Rite Aid | Valeant Shows the Risk of Follow the Leader | James Staley Named Chief of Barclays", "document_type": "blogpost", "abstract": "Walgreens to Buy Rite Aid | Valeant Shows the Risk of Follow the Leader | James Staley Named Chief of Barclays", "lead_paragraph": null}